Cargando…

Evaluation of homocystein and asymmetric dimethyl arginine levels in patients with coronary slow flow phenomenon

BACKGROUND: Previous studies have demonstrated that homocysteine and asymmetric dimethyl arginine (ADMA) levels were strongly associated with cardiovascular diseases including coronary artery disease. The aim of this study was to investigate the role of plasma homocysteine and ADMA levels in the pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demirci, Erkan, Çelik, Oğuzhan, Kalçık, Macit, Bekar, Lütfü, Yetim, Mucahit, Doğan, Tolga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Akadémiai Kiadó 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044542/ https://www.ncbi.nlm.nih.gov/pubmed/32148911 http://dx.doi.org/10.1556/1646.11.2019.07

Ejemplares similares

A rare complication of percutaneous coronary intervention: Coronary pseudoaneurysm formation
por: Çelik, Oğuzhan, et al.
Publicado: (2017)

Comparison of aortic pressures and aortic elastic properties between patients with end-stage renal disease and healthy controls
por: Kalçık, Macit, et al.
Publicado: (2019)

Echocardiographic measurement of epicardial adipose tissue thickness in patients with microvascular angina
por: Kalçık, Macit, et al.
Publicado: (2019)

Evaluation of ghrelin levels and endothelial functions in patients with coronary slow flow phenomenon
por: Çelik, Oğuzhan, et al.
Publicado: (2017)

Design and rationale for the ASSOS study: Appropriateness of aspirin use in medical outpatients a multicenter and observational study
por: Çelik, Oğuzhan, et al.
Publicado: (2018)

Inappropriate Use of Aspirin in Real-Life Cardiology Practice: Results from the Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study (ASSOS) Study
por: Çelik, Oğuzhan, et al.
Publicado: (2021)

Homocysteine levels in patients with coronary slow flow phenomenon: A meta-analysis
por: Yu, Hong, et al.
Publicado: (2023)

An Evaluation of Aspirin Treatment Preferences of Physicians in Hypertensive Patients in Terms of Current Guidelines: A Subgroup Analysis of the ASSOS Trial in Turkey
por: Memiç Sancar, Kadriye, et al.
Publicado: (2022)

Recognition of asymmetrically dimethylated arginine by TDRD3
por: Sikorsky, Tomas, et al.
Publicado: (2012)

Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis
por: Di Franco, Manuela, et al.
Publicado: (2018)

Association of Interleukin-1 Gene cluster polymorphisms with coronary slow flow phenomenon
por: Mutluer, Ferit Onur, et al.
Publicado: (2018)

The clinical effects of l‐arginine and asymmetric dimethylarginine: implications for treatment in secondary Raynaud's phenomenon
por: Curtiss, P., et al.
Publicado: (2018)

How Did the Updated 2019 European Society of Cardiology/European Atherosclerosis Society Risk Categorization for Patients with Diabetes Affect the Risk Perception and Lipid Goals? A Simulated Analysis of Real-life Data from EPHESUS Study
por: Başaran, Özcan, et al.
Publicado: (2023)

Association of circulating angiogenesis inhibitors and asymmetric dimethyl arginine with coronary plaque burden
por: Charytan, David M., et al.
Publicado: (2015)

Increased asymmetrical dimethyl-arginine suppresses nitric oxide production in Pseudomonas aeruginosa sepsis
por: Sousse, L, et al.
Publicado: (2009)

Proteome-Wide Alterations of Asymmetric Arginine Dimethylation Associated With Pancreatic Ductal Adenocarcinoma Pathogenesis
por: Wei, Meijin, et al.
Publicado: (2020)

Rationale, Design, and Methodology of the APOLLON trial: A comPrehensive, ObservationaL registry of heart faiLure with mid-range and preserved ejectiON fraction
por: Özlek, Bülent, et al.
Publicado: (2018)

Transpulmonary vascular gradients of nitric oxide pathway metabolites and asymmetrical dimethyl-L-arginine in the flow – or pressure-overloaded pulmonary vasculature
por: Kreuder, J, et al.
Publicado: (2003)

Coronary Slow Flow Phenomenon Clinical Findings and Predictors
por: Sanati, Hamidreza, et al.
Publicado: (2016)

Association of serum asymmetric dimethyl-arginine and troponin I levels as a risk of myocardial infarction in thalassemia
por: Helmi, Nawal, et al.
Publicado: (2018)

Asymmetric arginine dimethylation of cytosolic RNA and DNA sensors by PRMT3 attenuates antiviral innate immunity
por: Zhu, Junji, et al.
Publicado: (2023)

Plasma Homocysteine is Not Related to the Severity of Microangiopathy in Secondary Raynaud Phenomenon
por: Jacomella, Vincenzo, et al.
Publicado: (2011)

Slow Coronary Flow Phenomenon and Increased Platelet Volume Indices
por: Seyyed-Mohammadzad, Mir Hossein, et al.
Publicado: (2014)

Clinical Profile and Outcome in Patients with Coronary Slow Flow Phenomenon
por: Zhu, Xiaogang, et al.
Publicado: (2019)

Prevalence and predictors of slow coronary flow phenomenon in Kermanshah province
por: Rouzbahani, Mohammad, et al.
Publicado: (2021)

A violist with asymmetrical Raynaud’s phenomenon
por: Silva, Beatriz C, et al.
Publicado: (2023)

Nitric oxide and asymmetric dimethyl arginine (ADMA) levels in an experimental hydronephrotic kidney caused by unilateral partial ureteral obstruction
por: Alan, Cabir, et al.
Publicado: (2016)

Evaluation of serum Asymmetric Dimethyl Arginine concentrations in coronary artery disease patients without traditional cardiovascular risk factors
por: Ghayour-Mobarhan, Majid, et al.
Publicado: (2018)

Asymmetric and Symmetric Protein Arginine Dimethylation: Concept and Postprandial Effects of High-Fat Protein Meals in Healthy Overweight Men
por: Bollenbach, Alexander, et al.
Publicado: (2019)

Melhora da Pressão Arterial após Jejum Intermitente na Hipertensão: O Sistema Renina-Angiotensina e o Sistema Nervoso Autônomo Podem Funcionar?
por: Demirci, Erkan, et al.
Publicado: (2023)

Coronary Slow Flow Phenomenon Leads to ST Elevation Myocardial Infarction
por: Sen, Taner
Publicado: (2013)

Complete blood cell count components and coronary slow-flow phenomenon
por: Arjmand, Nasim, et al.
Publicado: (2016)

QT interval and P wave dispersion in slow coronary flow phenomenon
por: Eshraghi, Ali, et al.
Publicado: (2018)

Coronary Slow Flow Phenomenon and Atrioventricular Block: A Case Report
por: Masoumi, Mohammad, et al.
Publicado: (2017)

Abnormality in coronary slow flow phenomenon detected by nailfold microcirculation microanalysis
por: Zhang, He-Xi, et al.
Publicado: (2021)

Coronary Microvascular Spasm as the Underlying Cause of the Angiographic Slow Flow Phenomenon
por: Martínez Pereyra, Valeria, et al.
Publicado: (2020)

Incremental value of transesophageal echocardiography in the evaluation of patients before percutaneous closure of atrial septal defects
por: Kalçık, Macit, et al.
Publicado: (2019)

A well validated risk stratification index predicts weak material and fetal outcomes in pregnant women with cardiovascular disease
por: Güner, Ahmet, et al.
Publicado: (2021)

The effect of blood cell count on coronary flow in patients with coronary slow flow phenomenon
por: Soylu, Korhan, et al.
Publicado: (2014)

Interleukin-1 gene cluster polymorphisms associated with coronary slow flow phenomenon
por: Yasri, Sora, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3ap0rl086ac2jbpvd6179c6jcr